Trailing-twelve-month (TTM) revenue is $680.89 Million with a year-over-year growth of +48.52%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $156,935,799 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-20 |
| Q4 FY2025Period ended 2025-12-31 | $165,198,822 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-21 |
| Q1 FY2026Period ended 2026-03-31 | $159,928,016 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $198,831,080 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-19 |
| TTM revenue | $680,893,717 |
Current P/S: $3,914,185,382 market capitalization ÷ $680,893,717 TTM revenue = 5.75x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $198.83M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 10 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:25:50.578Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Other Member | $4M | $1M |
| Other Revenue Member | N/A | $25M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| CANADA | N/A | $8M |
| HONG KONG | $7M | $7M |
| Other Member | $5M | $11M |
| SINGAPORE | $11M | $13M |
| UNITED STATES | $355M | $516M |
$680.89M
$680.89 Million
+48.52%
vs. $458.45M a year ago (TTM)
+48.96%
3 Year compound annual growth rate
1 Year
+48.52%
3 Year
+48.96%
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $571.00M | +$180.77M | +46.32% |
| 2024 | $390.23M | +$627,102 | +0.16% |
| 2023 | $389.60M | +$1.27M | +0.33% |
TTM Growth
+48.52%
3-Year CAGR
+48.96%
5-Year CAGR
N/A
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
